Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06600009
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-09-12
Brief Title:
Treatment Persistence of Biologics in Patients with PsA in Japan Retrospective Cohort Study Using a Claims Database
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Treatment Persistence of Biologics in Patients with PsA in Japan Retrospective Cohort Study Using a Claims Database The FLYWAY Study
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FLYWAY
Brief Summary:
This study was a retrospective non-interventional cohort study with secondary use of data from the Medical Data Vision MDV hospital-based database The study setting was defined as follows
The inclusion period covered 01 February 2015 to 30 September 2020
The study period covered 01 August 2014 to 30 September 2021 inclusive
The index date was defined as the date of the first prescription of secukinumab or adalimumab within the inclusion period
The pre-index period was defined as the 6-month period before the index date exclusive
Patients were followed until death discontinuation of treatments of interest or end of the study period whichever occurred first
The inclusion period covered 01 February 2015 to 30 September 2020
The study period covered 01 August 2014 to 30 September 2021 inclusive
The index date was defined as the date of the first prescription of secukinumab or adalimumab within the inclusion period
The pre-index period was defined as the 6-month period before the index date exclusive
Patients were followed until death discontinuation of treatments of interest or end of the study period whichever occurred first
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None